Exscientia Plc American Depositary Shares

EXAI

시가총액 US$6.33억

OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced the advancement of two additional discovery programmes within its collaboration with Sanofi, with Exscientia receiving an aggregate of $15 million in milestone payments. Both lead compounds have met the product profile requirements, set by both Exscientia and Sanofi, to enable a transition to the lead optimisation phase within the collaboration. Both programmes have also shown a high level of differentiation in earl.

NEW YORK, NY / ACCESSWIRE / October 11, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) , relating to its proposed merger with Exscientia PLC.

OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced three abstracts to be presented at the 36th EORTC-NCI-AACR (ENA) Symposium 2024 from October 23-25, in Barcelona, Spain. “As our precision-designed LSD1 and MALT1 inhibitors continue to progress towards the clinic, we are excited to share new preclinical data from both programmes,” said David Hallett, Ph.D., interim Chief Executive Officer and Chief Scientific Officer of Exscientia. “These posters, as well as an add.

SAN MATEO, Calif.--(BUSINESS WIRE)--Brilliant, the designer and manufacturer of innovative smart home controls and home automation systems shares its acquisition by Almeida Strategic Investments, led by brothers Evan and Michael Almeida, in partnership with David Blum, owner of Cullinan Holdings. The private investment fuels the next generation of innovation for Brilliant's award-winning smart home controls, switches, and plugs trusted in thousands of homes in North America. The new organizatio.

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Methode Electronics, Inc. (MEI) Investors.

ANNAPOLIS, Md.--(BUSINESS WIRE)--BreachBits is pleased to announce its collaboration with SecurityStudio for 2024. SecurityStudio is a cyber risk management platform that focuses on holistic information security for your organization, team, and vendors. BreachBits delivers security and compliance capabilities via the BreachRisk platform. BreachRisk leverages AI and automation to provide scalable cyber risk monitoring and testing from an attacker's perspective. These solutions empower organizati.

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has commented that the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings of “a+” (Excellent) of American National Insurance Company (ANICO) and its affiliates, American National Life Insurance Company of Texas and American National Life Insurance Company of New York (Glenmont, NY), collectively known as American National Group (ANG), remain unchanged following an announced coinsurance arrangement whereby ANG will cede $3.5.

DALLAS--(BUSINESS WIRE)--Suffolk, one of the largest and most innovative real estate and construction enterprises in the country, is proud to announce that the Dallas Business Journal has named its Dallas office as one of its Best Places to Work for the second year in a row. The annual list recognizes North Texas companies that have gone above and beyond to create an exemplary workplace, and Suffolk's consecutive wins highlight the growing impact the local team has on the region. Suffolk's Dall.

OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced that David Hallett, interim Chief Executive Officer and Chief Scientific Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024 at 7:00 a.m. EDT (12:00 p.m. BST). A live webcast of the fireside chat will be available on the Company's website, under the “Investors & Media” section at investors.exscientia.ai. An archived replay of.

OXFORD, U.K.--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI): Recent advancements in the Company's pipeline, collaborations and operations, as well as financial results for the second quarter and first half 2024, are summarised below. “Last week, we announced that Exscientia entered into a definitive agreement to combine with Recursion Pharmaceuticals,” said David Hallett, Ph.D., interim Chief Executive Officer and Chief Scientific Officer of Exscientia. “When we bring together our platforms at.